A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.

Nademanee, Auayporn; Forman, Stephen; Molina, Arturo; Fung, Henry; Smith, David; Dagis, Andy; Kwok, Cheuk; Yamauchi, Dave; Anderson, Anne-Line; Falk, Peter; Krishnan, Amrita; Kirschbaum, Mark; Kogut, Neil; Nakamura, Ryotaro; O'donnell, Margaret; Parker, Pablo; Popplewell, Leslie; Pullarkat, Vinod; Rodriguez, Roberto; Sahebi, Firoozeh; Smith, Eileen; Snyder, David; Stein, Anthony; Spielberger, Ricardo; Zain, Jasmine; White, Christine; Raubitschek, Andrew

Nademanee, Auayporn; Forman, Stephen; Molina, Arturo; Fung, Henry; Smith, David; Dagis, Andy; Kwok, Cheuk; Yamauchi, Dave; Anderson, Anne-Line; Falk, Peter; Krishnan, Amrita; Kirschbaum, Mark; Kogut, Neil; Nakamura, Ryotaro; O'donnell, Margaret; Parker, Pablo; Popplewell, Leslie; Pullarkat, Vinod; Rodriguez, Roberto; Sahebi, Firoozeh; Smith, Eileen; Snyder, David; Stein, Anthony; Spielberger, Ricardo; Zain, Jasmine; White, Christine; Raubitschek, Andrew.

Affiliation

Nademanee A; Division of Hematology and Hemapoietic Cell Transplantation, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010, USA. anademanee@coh.org

Blood ; 106(8): 2896-902, 2005 Oct 15.

Article in En | MEDLINE | ID: mdl-16002426

Subject(s)

Antibodies, Monoclonal/therapeutic use; Cyclophosphamide/therapeutic use; Etoposide/therapeutic use; Lymphoma, Non-Hodgkin/diagnosis; Lymphoma, Non-Hodgkin/therapy; Radioimmunotherapy; Stem Cell Transplantation; Adult; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/adverse effects; Cyclophosphamide/administration & dosage; Cyclophosphamide/adverse effects; Drug Therapy, Combination; Etoposide/administration & dosage; Etoposide/adverse effects; Female; Humans; Lymphoma, Non-Hodgkin/immunology; Lymphoma, Non-Hodgkin/surgery; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Survival Rate; Transplantation, Autologous; Yttrium Radioisotopes/administration & dosage; Yttrium Radioisotopes/adverse effects; Yttrium Radioisotopes/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Radioimmunotherapy / Cyclophosphamide / Stem Cell Transplantation / Etoposide / Antibodies, Monoclonal Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2005 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google